Publicacions en què col·labora amb Gema Moreno Bueno (66)

2024

  1. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation

    Virchows Archiv

2023

  1. Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

    Cancers, Vol. 15, Núm. 6

2022

  1. Gasdermin-B Pro-Tumor Function in Novel Knock-in Mouse Models Depends on the in vivo Biological Context

    Frontiers in Cell and Developmental Biology, Vol. 10

  2. Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study

    Journal of Personalized Medicine, Vol. 12, Núm. 11

2019

  1. Intracellular delivery of an antibody targeting gasdermin-b reduces her2 breast cancer aggressiveness

    Clinical Cancer Research, Vol. 25, Núm. 15, pp. 4846-4858

2017

  1. Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer

    Journal of Pathology, Vol. 241, Núm. 4, pp. 475-487

2016

  1. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer

    Oncotarget, Vol. 7, Núm. 35, pp. 56295-56308

2015

  1. A role for the transducer of the Hippo pathway, TAZ, in the development of aggressive types of endometrial cancer

    Modern Pathology, Vol. 28, Núm. 11, pp. 1492-1503

  2. Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873

  3. Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

    International Journal of Cancer, Vol. 136, Núm. 4, pp. E62-E73

2014

  1. A 9-protein biomarker molecular signature for predicting histologic type in endometrial carcinoma by immunohistochemistry

    Human Pathology, Vol. 45, Núm. 12, pp. 2394-2403

  2. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition

    Journal of Pathology, Vol. 232, Núm. 3, pp. 319-329

2013

  1. Endometrial carcinoma: Molecular alterations involved in tumor development and progression

    Oncogene, Vol. 32, Núm. 4, pp. 403-413

  2. Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis

    Human Pathology, Vol. 44, Núm. 2, pp. 244-254

2012

  1. The EMT signaling pathways in endometrial carcinoma

    Clinical and Translational Oncology, Vol. 14, Núm. 10, pp. 715-720

  2. The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells

    Oncogene, Vol. 31, Núm. 16, pp. 2049-2061

2011

  1. KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels

    American Journal of Pathology, Vol. 178, Núm. 4, pp. 1529-1543

  2. Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

    EMBO Molecular Medicine, Vol. 3, Núm. 9, pp. 528-544

  3. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

    Journal of Pathology, Vol. 223, Núm. 1, pp. 72-80

2010

  1. Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition

    Molecular Cancer, Vol. 9